| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |